30 March 2015
Concurrent Technologies Plc
Grant of Share Options
Concurrent Technologies Plc ("the Company"), a world leading specialist in the design and manufacture of high-end embedded computer products for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, announces, that on 26 March 2015, the following Directors were each granted ordinary share options in the Company, all at an exercise price of 39.00p per share, as noted below. These options have an exercise period of between three and ten years and are conditional on an average weighted compound earnings per share growth of a minimum of 2.5% per annum:
|
Director |
Ordinary Shares Held |
% of Share Capital |
Options Granted |
Total Number of Share Options Held |
|
Jane Annear |
1,836,596 |
2.5% |
400,000 |
450,630 |
|
David Evans-Hughes |
939,451 |
1.3% |
400,000 |
450,630 |
|
Glen Fawcett |
1,672,431 |
2.3% |
400,000 |
450,630 |
Enquiries:
|
Concurrent Technologies Plc |
+44 (0)1206 752 626 |
|
|
|
|
Newgate (Financial PR) Robyn McConnachie |
|
|
|
|
|
Cenkos Securities plc (NOMAD) |
|
Note to Editors:
About Concurrent Technologies Plc
Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel® processors, including the latest 4th generation Intel® Core™ i7, 3rd generation Intel® Core™ i7, 2nd generation Intel® Core™ i7, Intel® Core™ i7 processors and Intel® Atom™ processors, the Company offers a wide range of computer products which are designed to be compliant with industry specifications including those for products used in extremely harsh environments.
For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk.
All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.